RU2006107600A - Glucagon-like peptides-1 derivatives (GLP-1) - Google Patents
Glucagon-like peptides-1 derivatives (GLP-1) Download PDFInfo
- Publication number
- RU2006107600A RU2006107600A RU2006107600/04A RU2006107600A RU2006107600A RU 2006107600 A RU2006107600 A RU 2006107600A RU 2006107600/04 A RU2006107600/04 A RU 2006107600/04A RU 2006107600 A RU2006107600 A RU 2006107600A RU 2006107600 A RU2006107600 A RU 2006107600A
- Authority
- RU
- Russia
- Prior art keywords
- ethoxy
- glp
- lys
- acetyl
- aib
- Prior art date
Links
- 0 CC(C)(C**N[C@@](CCCCNC(COCCOCCN)=O)C(O)=O)N*N*P***C(C(C)(C)N([P-])SS*S*PC(C(C)(C)NC(C(Cc1cnc[n]1)N)=O)=O)=O Chemical compound CC(C)(C**N[C@@](CCCCNC(COCCOCCN)=O)C(O)=O)N*N*P***C(C(C)(C)N([P-])SS*S*PC(C(C)(C)NC(C(Cc1cnc[n]1)N)=O)=O)=O 0.000 description 5
- WLFFBLHKUVEGQN-UHFFFAOYSA-N CCCCCCCCCCCCCCCNC(C(O)=O)=O Chemical compound CCCCCCCCCCCCCCCNC(C(O)=O)=O WLFFBLHKUVEGQN-UHFFFAOYSA-N 0.000 description 1
- SFWPKKAWFSDSPB-UHFFFAOYSA-N CCc1c(C)[n](C(c(cc2)ccc2Cl)=O)c(cc2)c1cc2OC Chemical compound CCc1c(C)[n](C(c(cc2)ccc2Cl)=O)c(cc2)c1cc2OC SFWPKKAWFSDSPB-UHFFFAOYSA-N 0.000 description 1
Claims (74)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200301367 | 2003-09-19 | ||
DKPA200301367 | 2003-09-19 | ||
US50573903P | 2003-09-25 | 2003-09-25 | |
US60/505,739 | 2003-09-25 | ||
US52684703P | 2003-12-04 | 2003-12-04 | |
DKPA200301789 | 2003-12-04 | ||
US60/526,847 | 2003-12-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006107600A true RU2006107600A (en) | 2007-10-27 |
RU2401276C2 RU2401276C2 (en) | 2010-10-10 |
Family
ID=38955314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006107600/04A RU2401276C2 (en) | 2003-09-19 | 2004-09-17 | Glucagon-like peptide-1 (glp-1) derivatives |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2401276C2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8129343B2 (en) | 2005-03-18 | 2012-03-06 | Novo Nordisk A/S | Acylated GLP-1 compounds |
US8513192B2 (en) | 2009-01-22 | 2013-08-20 | Novo Nordisk A/S | Stable growth hormone compounds resistant to proteolytic degradation |
US8603972B2 (en) | 2005-03-18 | 2013-12-10 | Novo Nordisk A/S | Extended GLP-1 compounds |
US8779109B2 (en) | 2010-01-22 | 2014-07-15 | Novo Nordisk Health Care Ag | Growth hormones with prolonged in-vivo efficacy |
RU2525393C2 (en) * | 2009-01-23 | 2014-08-10 | Ново Нордиск А/С | Fgf21 derivatives with albumin binding agent a-b-c-d-e- and their application |
US8841249B2 (en) | 2009-08-06 | 2014-09-23 | Novo Nordisk A/S | Growth hormones with prolonged in-vivo efficacy |
RU2531590C2 (en) * | 2010-04-27 | 2014-10-20 | Бета Фармасьютикалс,Ко,Лтд. | Glucagon-like peptide-1 analogues and using them |
US8865868B2 (en) | 2008-08-06 | 2014-10-21 | Novo Nordisk Healthcare Ag | Conjugated proteins with prolonged in vivo efficacy |
US9211342B2 (en) | 2010-01-22 | 2015-12-15 | Novo Nordisk Healthcare Ag | Stable growth hormone compounds resistant to proteolytic degradation |
US11045523B2 (en) | 2013-04-05 | 2021-06-29 | Novo Nordisk Healthcare Ag | Formulation of growth hormone albumin-binder conjugate |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6352806B2 (en) | 2011-09-23 | 2018-07-04 | ノヴォ ノルディスク アー/エス | New glucagon analogues |
BR112015025464A2 (en) | 2013-04-18 | 2017-10-10 | Novo Nordisk As | stable, prolonged glp-1 / glucagon receptor coagonists for medical use |
US10570184B2 (en) | 2014-06-04 | 2020-02-25 | Novo Nordisk A/S | GLP-1/glucagon receptor co-agonists for medical use |
-
2004
- 2004-09-17 RU RU2006107600/04A patent/RU2401276C2/en active
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8129343B2 (en) | 2005-03-18 | 2012-03-06 | Novo Nordisk A/S | Acylated GLP-1 compounds |
US8536122B2 (en) | 2005-03-18 | 2013-09-17 | Novo Nordisk A/S | Acylated GLP-1 compounds |
US8603972B2 (en) | 2005-03-18 | 2013-12-10 | Novo Nordisk A/S | Extended GLP-1 compounds |
US8865868B2 (en) | 2008-08-06 | 2014-10-21 | Novo Nordisk Healthcare Ag | Conjugated proteins with prolonged in vivo efficacy |
US8513192B2 (en) | 2009-01-22 | 2013-08-20 | Novo Nordisk A/S | Stable growth hormone compounds resistant to proteolytic degradation |
RU2525393C2 (en) * | 2009-01-23 | 2014-08-10 | Ново Нордиск А/С | Fgf21 derivatives with albumin binding agent a-b-c-d-e- and their application |
US8841249B2 (en) | 2009-08-06 | 2014-09-23 | Novo Nordisk A/S | Growth hormones with prolonged in-vivo efficacy |
US8779109B2 (en) | 2010-01-22 | 2014-07-15 | Novo Nordisk Health Care Ag | Growth hormones with prolonged in-vivo efficacy |
US9211342B2 (en) | 2010-01-22 | 2015-12-15 | Novo Nordisk Healthcare Ag | Stable growth hormone compounds resistant to proteolytic degradation |
US9695226B2 (en) | 2010-01-22 | 2017-07-04 | Novo Nordisk Healthcare Ag | Growth hormones with prolonged in-vivo efficacy |
RU2531590C2 (en) * | 2010-04-27 | 2014-10-20 | Бета Фармасьютикалс,Ко,Лтд. | Glucagon-like peptide-1 analogues and using them |
US11045523B2 (en) | 2013-04-05 | 2021-06-29 | Novo Nordisk Healthcare Ag | Formulation of growth hormone albumin-binder conjugate |
Also Published As
Publication number | Publication date |
---|---|
RU2401276C2 (en) | 2010-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070203058A1 (en) | Novel Glp-1 Derivatives | |
US11208451B2 (en) | Protein and protein conjugate for diabetes treatment, and applications thereof | |
RU2006107600A (en) | Glucagon-like peptides-1 derivatives (GLP-1) | |
US20200046725A1 (en) | Prodrug Comprising a Drug Linker Conjugate | |
KR101963202B1 (en) | Oxyntomodulin analogue | |
KR101352225B1 (en) | Novel Exendin variant and conjugate thereof | |
US20100184641A1 (en) | Novel Plasma Protein Affinity Tags | |
EP1478233B1 (en) | Method for administering glp-1 molecules | |
US20090062192A1 (en) | Dimeric Peptide Agonists of the Glp-1 Receptor | |
EP0929576A1 (en) | Glp-2 derivatives | |
JP2002510193A (en) | Glucagon-like peptide-1 analog | |
RU2625015C2 (en) | Site-specific monophylated analyges of excendin and the method of their production | |
RU2006120079A (en) | Glucagon-like Peptides-1 Derivatives (GLP-1) | |
EP2514407A1 (en) | Stable non-aqueous pharmaceutical compositions | |
WO1998008871A1 (en) | Glp-1 derivatives | |
ZA200602000B (en) | Albumin-binding derivatives of therapeutic peptides | |
JP2010043001A (en) | Glp-1 derivative and use thereof | |
JP2002506792A (en) | N-terminal modified GLP-1 derivative | |
US20220275029A1 (en) | Compositions and particles for payload delivery | |
EP1060192A2 (en) | Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates | |
US20080045450A1 (en) | GLP-2 Derivatives | |
AU3847897C1 (en) | GLP-1 derivatives |